Update: Moderate lifetime drinking may lead to lower Alzheimer-related beta amyloid deposits in the brain

By SharpBrains | April 24, 2020

__ Time for a new edi­tion of Sharp­Brains’ e‑newsletter. #1. First of all, it’s not all bad news this month. Study finds that mod­er­ate life­time drink­ing may lead to low­er Alzheimer-relat­ed beta amy­loid deposits in the brain #2. And, talk about per­son­al­ized med­i­cine! This fas­ci­nat­ing study show­ing how brain imag­ing (fMRI) + machine learn­ing + inten­sive, non-invasive…

Read More

Update: Think twice before taking Adderall as cognitive enhancer — it may worsen your working memory

By SharpBrains | September 28, 2018

___ Dear read­er, It’s time for Sharp­Brains month­ly e‑newsletter, start­ing in this occa­sion with an impor­tant arti­cle by Duke Uni­ver­si­ty’s Dr. David Rabin­er rais­ing con­cerns about the grow­ing non-med­i­cal use of ADHD drugs. New research: Do ADHD drugs real­ly help col­lege stu­dents with­out ADHD? Mind­ful­ly debunk­ing four med­i­ta­tion myths Cog­ni­tive train­ing & reme­di­a­tion works, espe­cial­ly in schiz­o­phre­nia and healthy aging New…

Read More

Cognitive Enhancement via Pharmacology AND Neuropsychology, in The New Executive Brain

By Alvaro Fernandez | August 30, 2009

(Edi­tor’s Note: giv­en the grow­ing media atten­tion to three appar­ent­ly sep­a­rate worlds ‑cog­ni­tive enhance­ment via drugs, brain fit­ness train­ing soft­ware, com­put­er­ized neu­rocog­ni­tive assessments‑, I found it refresh­ing to see our co-founder Elkhonon Gold­berg intro­duce the top­ic of cog­notrop­ic drugs with an inte­gra­tive per­spec­tive in the much updat­ed new edi­tion of his clas­sic book, now titled…

Read More